Jade Biosciences Inc
(JBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,069 | 9,122 | 23,491 | 32,180 | 60,901 |
| Marketable Securities | 73,133 | 90,212 | 98,948 | 103,019 | 89,195 |
| TOTAL | $110,760 | $103,239 | $124,232 | $137,603 | $152,470 |
| Non-Current Assets | |||||
| PPE Net | 232 | 260 | 288 | 316 | 245 |
| Other Non-Current Assets | 702 | 3,322 | 2,898 | 2,957 | 3,040 |
| TOTAL | $934 | $3,582 | $3,186 | $3,273 | $3,285 |
| Total Assets | $111,694 | $106,821 | $127,418 | $140,876 | $155,755 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,179 | 3,313 | 2,396 | 3,504 | 5,529 |
| Accrued Expenses | 12,366 | 11,760 | 14,821 | 10,770 | 7,376 |
| TOTAL | $17,020 | $15,518 | $17,637 | $14,725 | $13,284 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 276 | 399 | 325 | 428 | 545 |
| TOTAL | $276 | $399 | $325 | $428 | $545 |
| Total Liabilities | $17,296 | $15,917 | $17,962 | $15,153 | $13,829 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 823 | 821 | 794 | 789 | 788 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -211,385 | -186,610 | -163,424 | -143,011 | -123,448 |
| Other shareholders' equity | -83 | -33 | 237 | -195 | -223 |
| TOTAL | $94,398 | $90,904 | $109,456 | $125,723 | $141,926 |
| Total Liabilities And Equity | $111,694 | $106,821 | $127,418 | $140,876 | $155,755 |